Drugs and targets

curl "https://conductscience.org/api/drugs/v1?page=2"

Response

The first 2 of this page's 20 results. GET /api/drugs/v1?page=2

{
  "data": {
    "total": 12618,
    "results": [
      {
        "id": "CHEMBL53463",
        "title": "DOXORUBICIN",
        "name": "DOXORUBICIN",
        "summary": "Small molecule, CHEMBL53463. 1,443 trials, 365 with posted results.",
        "record": "/library/drugs/CHEMBL53463",
        "drug_type": "Small molecule",
        "brands": "Adriblastina",
        "counts": {
          "trials": 1443,
          "trials_with_results": 365,
          "targets": 1,
          "diseases": 216,
          "comparisons": 248,
          "papers": 1007,
          "tests": 0
        }
      },
      {
        "id": "CHEMBL44657",
        "title": "ETOPOSIDE",
        "name": "ETOPOSIDE",
        "summary": "Small molecule, CHEMBL44657. 1,468 trials, 340 with posted results.",
        "record": "/library/drugs/CHEMBL44657",
        "drug_type": "Small molecule",
        "brands": "Toposar, Vepesid",
        "counts": {
          "trials": 1468,
          "trials_with_results": 340,
          "targets": 2,
          "diseases": 218,
          "comparisons": 250,
          "papers": 968,
          "tests": 3
        }
      }
    ],
    "columns": [
      {
        "key": "name",
        "label": "Drug",
        "under": "brands"
      },
      {
        "key": "id",
        "label": "ChEMBL ID",
        "under": "drug_type"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.trials_with_results",
        "label": "With posted results"
      },
      {
        "key": "counts.targets",
        "label": "Targets"
      },
      {
        "key": "counts.diseases",
        "label": "Diseases"
      }
    ],
    "order": "Most trials with posted results first",
    "kinds": {
      "all": 12618,
      "with-results": 5231
    }
  },
  "release": "pipelines-2026-09-18-0.3.1",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ConductCognition's list of its tests",
      "license": "Our own data: ConductCognition's list of its tests, https://conductcognition.com",
      "notice": null,
      "short": "Our own data"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "No license stated"
    },
    {
      "source": "NLM's MeSH",
      "license": "NLM's",
      "notice": null,
      "short": "NLM's terms"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubMed",
      "license": "NLM's terms",
      "notice": null,
      "short": "NLM's terms"
    }
  ],
  "next": "/api/drugs/v1?page=3",
  "request_id": "FCx5lE3xRBiuHz7B"
}